Fogarty International Center; Notice of Meeting, 12958-12959 [2018-05989]
Download as PDF
<![CDATA[
12958
Federal Register / Vol. 83, No. 58 / Monday, March 26, 2018 / Notices
Dated: March 20, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: March 28, 2018.
Time: 8:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Altered Neuronal Circuits, Receptors and
Networks in HIV-Induced Central Nervous
System (CNS) Dysfunction.
Date: March 29, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, Rockledge Drive, Room
3190, Bethesda, MD 20892, 301–827–7480.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
16:38 Mar 23, 2018
Jkt 244001
[FR Doc. 2018–05986 Filed 3–23–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846- 93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 20, 2018.
Sylvia L. Neal,
Program Analyst; Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–05987 Filed 3–23–18; 8:45 am]
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: April 4, 2018.
Time: 8:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Host Defense, Inflammation and
Vaccines.
Date: April 5, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review (CSR), National Institutes
of Health (NIH), 6701 Rockledge Dr., Room
4203, Bethesda, MD 20817, (301) 435–3566,
alok.mulky@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
Date: April 30, 2018.
Place: National Institutes of Health,
Lawton L. Chiles International House (Stone
House), Building 16, Conference Room, 16
Center Drive, Bethesda, MD 20892.
Closed Session: April 30, 2018, 1:00 p.m.
to 5:00 p.m.
Agenda: Second level review of grant
applications.
Date: May 1, 2018.
Place: Main Auditorium, Natcher
Conference Center (Building 45), National
Institutes of Health Campus, Bethesda, MD
20892.
Open Session: May 1, 2018, 8:30 a.m. to
5:30 p.m.
E:\FR\FM\26MRN1.SGM
26MRN1
Federal Register / Vol. 83, No. 58 / Monday, March 26, 2018 / Notices
Agenda: Topic one: What has been
accomplished and what is needed to advance
infectious disease research and achieve the
end of AIDS?
Topic two: Noncommunicable diseases:
how can we leverage existing research and
training platforms stem the tide of deaths and
disability?
Topic three: Global Brain Disorders: we’re
on the agenda, where do we go from here?
What are the priorities for advancing the
global mental health research agenda?
Topic four: Multi-generational models of
long-term capacity building: the trainees
become the trainers.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty International
Center, National Institutes of Health, 31
Center Drive, Room B2C02, Bethesda, MD
20892, (301) 496–1415, weymouthk@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Fish and Wildlife Service
[Docket No. FWS–HQ–IA–2018–0001;
FXIA16710900000–178–FF09A30000]
Endangered Species; Receipt of Permit
Applications
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of permit
applications.
AGENCY:
We, the U.S. Fish and
Wildlife Service, invite the public to
comment on applications to conduct
certain activities with foreign
endangered species. With some
exceptions, the Endangered Species Act
(ESA) prohibits activities with listed
species unless Federal authorization is
acquired that allows such activities. The
ESA also requires that we invite public
comment before issuing these permits.
DATES: We must receive comments by
April 25, 2018.
ADDRESSES: Document availability: The
applications, as well as any comments
and other materials that we receive, will
be available for public inspection online
in Docket No. FWS–HQ–IA–2018–0001
at https://www.regulations.gov.
Submitting Comments: You may
submit comments by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments
on Docket No. FWS–HQ–IA–2018–0001.
• U.S. mail or hand-delivery: Public
Comments Processing, Attn: Docket No.
FWS–HQ–IA–2018–0001; U.S. Fish and
Wildlife Service Headquarters, MS:
BPHC; 5275 Leesburg Pike, Falls
Church, VA 22041–3803.
When submitting comments, please
indicate the name of the applicant and
the PRT# at the beginning of your
comment. We will post all comments on
https://www.regulations.gov. This
generally means that we will post any
personal information you provide us
(see SUPPLEMENTARY INFORMATION for
more information).
FOR FURTHER INFORMATION CONTACT:
Joyce Russell, 703–358–2280.
SUPPLEMENTARY INFORMATION:
SUMMARY:
or to an address not in the ADDRESSES
section.
Please make your requests or
comments as specific as possible,
confine your comments to issues for
which we seek comments in this notice,
and explain the basis for your
comments. Include sufficient
information with your comments to
allow us to authenticate any scientific or
commercial data you include.
The comments and recommendations
that will be most useful and likely to
influence agency decisions are: (1)
Those supported by quantitative
information or studies; and (2) Those
that include citations to, and analyses
of, the applicable laws and regulations.
We will not consider or include in our
administrative record comments we
receive after the close of the comment
period (see DATES) or comments
delivered to an address other than those
listed above in ADDRESSES).
B. May I review comments submitted by
others?
Comments, including names and
street addresses of respondents, will be
available for public review at the street
address listed under ADDRESSES. The
public may review documents and other
information applicants have sent in
support of the application unless our
allowing viewing would violate the
Privacy Act or Freedom of Information
Act. Before including your address,
phone number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
A. How do I comment on submitted
applications?
[FR Doc. 2018–05989 Filed 3–23–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:38 Mar 23, 2018
Jkt 244001
C. Who will see my comments?
If you submit a comment via https://
www.regulations.gov, your entire
comment, including any personal
identifying information, will be posted
on the website. If you submit a
hardcopy comment that includes
personal identifying information, such
as your address, phone number, or
email address, you may request at the
top of your document that we withhold
this information from public review.
However, we cannot guarantee that we
will be able to do so.
You may submit your comments and
materials by one of the methods listed
under Submitting Comments in the
ADDRESSES section. We will not
consider comments sent by email or fax,
Dated: March 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
sradovich on DSK3GMQ082PROD with NOTICES
DEPARTMENT OF THE INTERIOR
12959
II. Background
To help us carry out our conservation
responsibilities for affected species, and
in consideration of section 10(a)(1)(A) of
the Endangered Species Act of 1973, as
I. Public Comment Procedures
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 83, Number 58 (Monday, March 26, 2018)]
[Notices]
[Pages 12958-12959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05989]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Fogarty
International Center Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: April 30, 2018.
Place: National Institutes of Health, Lawton L. Chiles
International House (Stone House), Building 16, Conference Room, 16
Center Drive, Bethesda, MD 20892.
Closed Session: April 30, 2018, 1:00 p.m. to 5:00 p.m.
Agenda: Second level review of grant applications.
Date: May 1, 2018.
Place: Main Auditorium, Natcher Conference Center (Building 45),
National Institutes of Health Campus, Bethesda, MD 20892.
Open Session: May 1, 2018, 8:30 a.m. to 5:30 p.m.
[[Page 12959]]
Agenda: Topic one: What has been accomplished and what is needed
to advance infectious disease research and achieve the end of AIDS?
Topic two: Noncommunicable diseases: how can we leverage
existing research and training platforms stem the tide of deaths and
disability?
Topic three: Global Brain Disorders: we're on the agenda, where
do we go from here? What are the priorities for advancing the global
mental health research agenda?
Topic four: Multi-generational models of long-term capacity
building: the trainees become the trainers.
Contact Person: Kristen Weymouth, Executive Secretary, Fogarty
International Center, National Institutes of Health, 31 Center
Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106,
Minority International Research Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special International Postdoctoral
Research Program in Acquired Immunodeficiency Syndrome; 93.168,
International Cooperative Biodiversity Groups Program; 93.934,
Fogarty International Research Collaboration Award; 93.989, Senior
International Fellowship Awards Program, National Institutes of
Health, HHS)
Dated: March 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-05989 Filed 3-23-18; 8:45 am]
BILLING CODE 4140-01-P
